IDXX vs NEOG
IDXX: IDEXX Laboratories is a global pet healthcare leader providing essential diagnostic, laboratory, and software solutions to veterinary practitioners worldwide. NEOG: Neogen is a global provider of diagnostics and biosecurity solutions dedicated to ensuring the safety and quality of the world's food and animal supply.
Side-by-side fundamentals
| Metric | IDXX | NEOG | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $513.14 | $11.71 | |
| Market cap | $40.4B | $2.6B | |
| P/E as of 2026-10-08 | 36.07 | n/a | |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | 2.04 | n/a | |
| Net margin | +24.6% | -0.9% | IDXX higher |
| Gross margin | +61.8% | +46.9% | IDXX higher |
| Operating margin | +31.6% | -2.5% | IDXX higher |
| ROE | +66.0% | -0.4% | IDXX higher |
| ROA | +31.6% | -0.2% | IDXX higher |
| Debt / equity as of 2026-09-03 | 0.60 | 0.38 | NEOG lower |
| Revenue growth (YoY) as of 2026-09-03 | +12.8% | -2.7% | IDXX higher |
| Revenue CAGR (3y) SEC XBRL | +8.5% | +1.9% | IDXX higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 0.94 | 0.31 | |
| 1-year return as of 2026-10-08 close | -18.5% | +101.2% | NEOG higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.